¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"First Response Ovulation Base InVt"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • base pair
    ¿°±â½Ö
  • base pair substitution
    ¿°±â½Öġȯ
  • base pairing
    ¿°±â¦Áþ±â
  • base unit
    ±âº»´ÜÀ§
  • buffer base
    ¿ÏÃæ¿°±â
  • conjugate base
    ¦¿°±â
  • cast base porcelain crown
    ÁÖÁ¶±âÄ¡°ü, ±âÀúºÎÁÖÁ¶µµÄ¡°ü
  • monoacidic base
    Àϻ꿰±â
  • negative base excess
    ¿ª¿°±â°úÀ×
  • ointment base
    ¿¬°í±âÁ¦
  • purine base
    Ǫ¸°¿°±â
  • skull base approach
    ¸Ó¸®¹Ù´Ú¼ö¼úÁ¢±Ù¹ý, µÎ°³Àú¼ö¼úÁ¢±Ù¹ý
  • vitreous base
    À¯¸®Ã¼¹Ù´Ú, À¯¸®Ã¼±âÀú
  • walking base
    º¸Æø
  • wound base
    »óó¹Ù´Ú, âÀú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • base pair
    ¿°±â½Ö
  • base pairing
    ¿°±â¦Áþ±â
  • base line shift
    ±âÁؼ±À̵¿
  • base pair substitution
    ¿°±â½Ö´ëÄ¡
  • buffer base
    ¿ÏÃæ¿°±â
  • conjugate base
    ¦¿°±â
  • monoacidic base
    Àϻ꿰±â
  • ointment base
    ¿¬°í±âÁ¦
  • purine base
    Ç»¸°¿°±â
  • vitreous base
    À¯¸®Ã¼¹Ù´Ú, À¯¸®Ã¼±âÀú
  • walking base
    º¸Æø
  • wound base
    »óó¹Ù´Ú, âÀú
  • case-base study
    ȯÀÚ¸ðÁý´Ü¿¬±¸
  • cast base porcelain crown
    ÁÖÁ¶±âÄ¡°ü, ±âÀúºÎÁÖÁ¶µµÄ¡°ü
  • egg-base culture media
    ´Þ°¿±âÃʹèÁö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • antibody response
    Ç×ü¹ÝÀÀ(¡­Úãëë).
  • approximate response
    ±Ù»ç¹ÝÀÀ
  • arousal reaction=arousal response
    °¢¼º¹ÝÀÀ(ÊÆá¥Úãëë)
  • frenquency response curve
    Á֯ļö ¹ÝÀÀ°î¼±
  • galvanic skin response =GSR
    Àü±âÇǺιÝÀÀ(ï³Ñ¨ù«Ý±Úãëë).
  • galvanic skin response audiometry
    ÇǺÎÀü±â¹ÝÀÀ û·Â°Ë»ç
  • heat shock response
    ¿­Ãæ°Ý¹ÝÀÀ
  • ideosyncratic drug response
    ƯÀ̼º ¾à¹° ¹ÝÀÀ
  • immune response
    ¸é¿ªÀÀ´ä.
  • immune response
    ¸é¿ª¹ÝÀÀ
  • immune response
    ¸é¿ªÀÀ´ä.
  • immune response
    ¸é¿ªÀÀ´ä.
  • immune response gene
    ¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ.
  • immune response gene
    ¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ
  • immune response suppression
    ¸é¿ª¹ÝÀÀ¾ïÁ¦<--¾ï¾Ð>
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • first degree burn
    1µµ¿­»ó<È­»ó>(ÀÏŹ¿­»ó<È­»ó>), È«¹Ý¼º ¿­»ó<È­»ó>.
  • first degree relative
    ÀϵîÄ£(ìéÔõöÑ).
  • first filial generation
    ÀâÁ¾ Á¦1¼¼´ë
  • first filial generation
    ÀÏ´ëÀâÁ¾(ìéÓÛíÚðú).
  • first finger
    Á¦ ÀÏÁö, ¾öÁö ¼Õ°¡¶ô.
  • first heart sound
    Á¦ÀϽÉÀ½.
  • first intention (healing)
    1Â÷¼º À¯ÇÕ(ÀÏÂ÷¼º À¯ÇÕ).
  • first meiotic devision
    ÀÏÂ÷°¨¼öºÐ¿­
  • first milk molar
    Á¦ÀÏÀ¯±¸Ä¡(¡­êáÏ¿öÍ).
  • first molar =posteriory cheek tooth
    Á¦Àϴ뱸ġ(ð¯ìéÓÞÏ¿öÍ).
  • first order neuron
    Á¦ÀÏÂ÷½Å°æ´ÜÀ§.
  • first pain
    ÀÏÂ÷Åë(ìéó­÷Ô).
  • first pass effect
    ÀÏÂ÷Åë°úÈ¿°ú.
  • first pass study
    ÀÏÂ÷Åë°ú°Ë»ç.
  • first pharyngeal arch
    ù°ÀεαÁÀÌ Ã¹Â°¾Æ°¡¹Ì±ÁÀÌ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Base of renal pyramid
    ÇǶó¹Ô¹Ù´Ú
    [¿¾ ¿ë¾î] ÃßüÀú
  • Base of lung
    ÇãÆÄ¹Ù´Ú
    [¿¾ ¿ë¾î] ÆóÀú
  • Atlas [First cervical vertebra]
    °í¸®»À [ȯÃß°ñ]
    [¿¾ ¿ë¾î] ȯÃß(Á¦1°æÃß)
  • Coccyx [First-fourth coccygeal vertebrae]
    ²¿¸®»À [ù°-³Ý°²¿¸®(ôÃß)»À] [¹Ì°ñ]
    [¿¾ ¿ë¾î] ¹Ì°ñ
  • Thoracic vertebrae(first-twelfth)
    µî(ôÃß)»À(ù°-¿­µÎ°) [ÈäÃß°ñ]
    [¿¾ ¿ë¾î] ÈäÃß°ñ
  • Cervical vertebrae(first-seventh)
    ¸ñ(ôÃß)»À(ù°-Àϰö°) [°æÃß°ñ]
    [¿¾ ¿ë¾î] °æÃß
  • Metatarsal bones(First-fifth)
    ¹ßÇ㸮»À(ù°-´Ù¼¸Â°)
    [¿¾ ¿ë¾î] ÁßÁ·(ô)°ñ(Á¦1-Á¦5)
  • Metacarpal bones(first-fifth)
    ¼ÕÇ㸮»À(ù°-´Ù¼¸Â°)
    [¿¾ ¿ë¾î] Áß¼ö(Àå)°ñ
  • Great[First] toe
    ¾öÁö¹ß°¡¶ô
    [¿¾ ¿ë¾î] ¹«Áö
  • Sacrum [First-fifth sacral vertebrae]
    ¾ûÄ¡»À [ù°-´Ù¼¸Â°¾ûÄ¡(ôÃß)»À] [õ°ñ]
    [¿¾ ¿ë¾î] õ°ñ
  • First polar body
    ÀÏÂ÷±ØÃ¼
    [¿¾ ¿ë¾î] ÀÏÂ÷±ØÃ¼
  • First arch
    ù°±ÁÀÌ
    [¿¾ ¿ë¾î] Á¦ÀϱÃ
  • First polar body
    ù°±ØÃ¼
    [¿¾ ¿ë¾î] ÀÏÂ÷±ØÃ¼
  • First aortic arch
    ù°´ëµ¿¸ÆÈ°
    [¿¾ ¿ë¾î] Á¦Àϴ뵿¸Æ±Ã
  • First posterior intercostal artery
    ù°µÚ°¥ºñ»çÀ̵¿¸Æ
    [¿¾ ¿ë¾î] Á¦1´Á°£µ¿¸Æ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • tertiary response
    »ïÂ÷´ëÀÀ (ß²ó­Óßëë)
  • acid-base balance
    »ê¿°±â±ÕÇü (ß«ç¤Ðñгû¬)
  • acid-base catalyst
    »ê¿°±âÃ˸Š(ß«ç¤ÐñõºØÚ)
  • acid-base equilibrium
    »ê¿°±âÆòÇü (ß«ç¤ÐñøÁû¬)
  • acid-base indicator
    »ê¿°±âÁö½Ã¾à (ß«ç¤Ðñò¦ãÆå·)
  • acid-base titration
    »ê¿°±â ÀûÁ¤ (ß«ç¤ÐñîêïÒ)
  • base
    ¿°±â(ç¤Ðñ)
  • base analogue
    ¿°±âÀ¯»ç¹°(ç¤Ðñ×¾ÞÄÚª)
  • base composition
    ¿°±â Á¶¼º(ç¤Ðñ ðÚà÷)
  • base excision repair
    ¿°±â ÀýÁ¦¼ö¼±(ç¤Ðñ ï·ð¶áóàË)
  • base line
    ¹Ù´Ú ¼±(àÊ)
  • base pair
    1. ¿°±â ¦ 2. ¿°±â ½Ö(äª)
  • base pair
    (Ó¤êÈ) base pair
  • base pairing
    "¿°±â(ç¤Ðñ) ¦Áþ±â, ¿°±â ¦Áö¿ò"
  • base-pairing rules
    ¿°±â ¦Áþ±â ±ÔÄ¢(ЮöÎ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ETO estimated time of ovulation
OIH Office of International Health; orthoiodohippurate; ovulation-inducing hormone
OM obtuse mental; occipitomental; occupational medicine; ocular movement; oculomotor; Osborne Mendel [r...
OV oculovestibular; office visit; osteoid volume; outflow volume; ovalbumin; ovary; overventilation; ov...
CER capital expenditure review; ceramide; conditioned emotional response; control electrical rhythm; cor...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
FPRNA First-pass radionuclide angiography
F(1) first
FDI first dorsal interosseous muscle
T(1) the first
kb 4.0-kilo base
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • biologic response modifier
    »ýü ¹ÝÀÀ º¯ÇüÀÚ
  • CNS ischemic response
    ÁßÃß ½Å°æ ÇãÇ÷ ¹ÝÀÀ
  • concentration-response curve
    ³óµµ ¹ÝÀÀ °î¼±
  • conditioned fear response
    Á¶°ÇÈ­ °øÆ÷ ¹ÝÀÀ
  • dorsal horn response
    ¹è°¢ ¹ÝÀÀ
  • dose response relationship
    ¹æ»ç¿ë·® ¹ÝÀÀ °ü°è, ¿ë·® ¹ÝÀÀ °ü°è
  • dose-response curve
    ¿ë·® ¹ÝÀÀ °î¼±
  • emotional defense response
    Á¤¼­Àû ¹æ¾î ¹ÝÀÀ
  • ensitization 1. administration of antigen to induce a primary immune response; priming; immunization. 2. exposure to allergen that results in the development of hypersensitivity. 3. the coating of erythrocytes with antibody so that they are subject to lys
    ³»¹ø
    ƯÈ÷ ¾È°Ë ¿¬ÀÇ.
  • evoked response
    À¯¹ß ¹ÝÀÀ
  • humoral immunologic response
    ü¾×¼º ¸é¿ª ¹ÝÀÀ
  • immediate response
    Ãʱ⠹ÝÀÀ
    ¾Ë·¹¸£±â ¹ÝÀÀ°ú °°ÀÌ À¯¹ßÀÎÀÚ¿¡ Á¢ÇÑ ÈÄ, ¸î ÃÊ-¸î ºÐ À̳»¿¡ ÃâÇöÇÏ´Â ¹ÝÀÀ.
  • immune response
    ¸é¿ª ¹ÝÀÀ
  • immunologic response
    ¸é¿ª ¹ÝÀÀ
    Ç׿ø¿¡ ³ëÃâµÊÀ¸·Î½á °³Ã¼ÀÇ ¹ÝÀÀ¼ºÀÌ Æ¯ÀÌÀûÀ¸·Î º¯È­ÇÑ »óÅÂ.
  • learned response
    ÇнÀ ¹ÝÀÀ
    ÇнÀÀ» ½ÃŰ´Â ÀÚ°¡ ÀǵµÇÑ ´ë·Î Çൿ. ¿¹¸¦ µé¸é Á¾ÀÌ ¿ï·Áµµ °³°¡ ħÀ» È긮´Â °ÍÀÌ ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
first molar First permanent molar, sixth permanent tooth or fourth deciduous tooth in the maxilla and mandible on either side of the midsagittal plane of the head following the arch form.
(05 Mar 2000)
first-order kinetics A term describing the reaction rate of a chemical reaction in which the rate is proportional to the concentration (in moles) of only one of the reactants. Such a reaction might have an equation like rate = k[A], where k is the reaction rate constant and [A] is the concentration of a reactant A.
(09 Oct 1997)
first-order reaction A reaction the rate of which is proportional to the concentration of the single substance undergoing change; radioactive decay is a first-order process, defined by the equation -(dN/dt)=kN, where N is the number of atoms subject to decay (reaction), t is time, and k is the first-order decay (reaction) constant, i.e., the fraction of all atoms decaying per unit of time.
See: decay constant, order.
(05 Mar 2000)
first parallel pelvic plane The upper opening of the true pelvis, bounded anteriorly by the pubic symphysis and the pubic crest on either side, laterally by the iliopectineal lines, and posteriorly by the promontory of the sacrum.
Synonym: apertura pelvis superior, aditus pelvis, first parallel pelvic plane, pelvic brim, pelvic inlet, pelvic plane of inlet, plane of inlet.
(05 Mar 2000)
first rank symptoms Those symptom's that, when present, indicate that the diagnosis of schizophrenia is likely, provided that organic or toxic aetiology is ruled out: delusion of control, thought broadcasting, thought withdrawal, thought insertion, hearing one's thoughts spoken aloud, auditory hallucinations that comment on one's behaviour, and auditory hallucinations in which two voices carry on a conversation.
Synonym: first rank symptoms, schneiderian first rank symptoms.
(05 Mar 2000)
first-set rejection Allograft transplantation between two organisms not previously sensitised to the graft tissue. Necrosis of the graft usually occurs within 10 days of transplantation.
(05 Mar 2000)
first stage of labour The part of labour when the cervix dilates fully (to 10 centimeters). The first stage of labour is also called the stage of dilatation.
(12 Dec 1998)
first temporal convolution A longitudinal gyrus on the lateral surface of the temporal lobe between the lateral (sylvian) fissure and the superior temporal sulcus.
Synonym: gyrus temporalis superior, first temporal convolution, superior temporal convolution.
(05 Mar 2000)
first visceral cleft <anatomy> The cleft between the hyoid and mandibular arches of the embryo; the external auditory meatus is developed from its dorsal portion.
Synonym: first visceral cleft.
(05 Mar 2000)
anamnestic response <immunology> Archaic term now replaced by such terms as secondary immune response, immune memory.
(18 Nov 1997)
audiometry, evoked response A form of electrophysiologic audiometry in which an analog computer is included in the circuit to average out ongoing or spontaneous brain wave activity. A characteristic pattern of response to a sound stimulus may then become evident. Evoked response audiometry is known also as electric response audiometry.
(12 Dec 1998)
auditory brainstem response audiometry An electrophysiologic measure of auditory function utilizing responses produced by the auditory nerve and the brainstem to repetitive acoustic stimuli.
(05 Mar 2000)
biological response modifier <pharmacology, oncology> A substance used in adjuvant therapy that takes advantage of the bodys own natural defense mechanisms to inhibit the growth of a tumour.
(16 Dec 1997)
biological response modifiers Substances that stimulate the body's response to infection and disease. The body naturally produces small amounts of these substances. Scientists can produce some of them in the laboratory in large amounts and use them in cancer treatment. Also called BRMs.
(12 Dec 1998)
biphasic response Two separate and distinct responses that are separated in time, immediate reaction to an antigenic challenge followed by a recurrence of symptoms after an interval of quiescence.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • data base
    µ¥ÀÌÅͺ£À̽º(ÀüÀÚ°è»ê±â¿ë Á¤º¸ÀÇ ÃàÀû ¹× ÀÌ Á¤º¸ÀÇ Á¦°ø ¼­ºñ½º)
  • data base management system
    (Àü»ê)µ¥ÀÌÅͺ£À̽º °ü¸® ½Ã½ºÅÛ(¾à DBMS)
  • forward base
    ÀüÁø±âÁö
  • free base
    ÇÁ¸® º£À̽º(ÄÚÄ«Àΰú ¿¡Å׸£ÀÇ È¥ÇÕ¹°)
  • full base
    ¸¸·ç
  • home base
    º»·ç
  • naval base
    ÇØ±º±âÁö
  • power base
    ¼¼·Â ±â¹Ý;ÁöÁö ¸ðü
  • prisoners base
    Áø »©¾Ñ±â ³îÀÌ
  • rate base
    (ÀâÁöÀÇ)º¸Áõ ºÎ¼ö(À̸¦ ¹ÙÅÁÀ¸·Î ±¤°í¿ä±ÝÀÌ Á¤ÇØÁü)
  • relay base
    Áß°è¼®
  • rocket base
    ¹Ì»çÀÏ ±âÁö
  • secondary base
    2·ç
  • time base
    ½Ã°£Ãà
  • first
    ÃÖÃÊÀÇ,ÃÖÃÊ·Î Á¦1
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á